Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 596 participants.
Also called NCT03519737
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 596 participants
- Sponsor
- Cerevast Medical, Inc.
- Registry
-
NCT03519737
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT03519737. Randomized; quadruple masking; primary purpose treatment. Start 2018-08-17 (actual); primary completion 2021-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke
- Acronym
- TRUST
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- tPA in combination with the Sonolysis Headframe (TUS)
- Intervention (Device)
- tPA in combination with the Sonolysis Headframe (Sham TUS)
- Lead sponsor
- Cerevast Medical, Inc.
Record details
- Record id
cardio:ct-nct03519737- Content hash
70b7e5adb103edfb2b53f975cbdd2518ae1e3560302f1bd1f19ce80b18572a5b